A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
MINNEAPOLIS — Chimeric antigen receptor (CAR) T-cell therapy in children with certain rheumatologic conditions appears to be ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
CAR-T therapy has transformed treatment for some blood cancers, with seven FDA-approved products and strong clinical responses in hematologic malignancies.
An update on CAR-T therapies for MM and B-cell NHL presented at the 2026 ONA Summit highlighted the integral role of oncology nurses in ensuring patients achieve optimal outcomes.
Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...
BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...
CAR-T cell therapy represents an innovative form of immunotherapy, wherein T cells are genetically modified to recognize and ...
Preclinical research has shown that CAR T cells directed against the urokinase plasminogen activator receptor can attack both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results